Paricalcitol and Klor-con drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Paricalcitol (paricalcitol) and Klor-con (potassium chloride). Common drug interactions include chronic kidney disease among females and fall among males.

The phase IV clinical study analyzes what interactions people have when they take Paricalcitol and Klor-con. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Paricalcitol?

Paricalcitol has active ingredients of paricalcitol. eHealthMe is studying from 1,278 Paricalcitol users. Check the latest studies of Paricalcitol.

What is Klor-con?

Klor-con has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 27,547 Klor-con users. Check the latest studies of Klor-con.

On Jul, 12, 2026

19 people who take Paricalcitol and Klor-con together, and have interactions are studied.

Paricalcitol and Klor-con drug interactions.

What are the common drug interactions of Paricalcitol and Klor-Con, by gender? *:

female:

Chronic kidney disease
Renal failure (kidney dysfunction)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Nephrogenic anaemia (anaemia due to kidney disease)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
Abasia (inability to walk)
Anaemia (lack of blood)
Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
Drug ineffective
Gait disturbance

male:

Fall
Asthenia (weakness)
Fatigue (feeling of tiredness)
Gait disturbance
Hepatic enzyme increased
Malaise (a feeling of general discomfort or uneasiness)
Urinary tract infection
Weight decreased
Anxiety
Arthralgia (joint pain)

What are the common drug interactions of Paricalcitol and Klor-Con, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Lung transplant
Lung transplant rejection (failure of lung transplant)

50-59:

Chronic kidney disease
Renal failure (kidney dysfunction)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
Abasia (inability to walk)
Cardiac failure
Cardiac failure congestive
Encephalopathy (functioning of the brain is affected by some agent or condition)
Gait disturbance
Generalised oedema (swelling all over the body)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)

60+:

Fall
Chronic kidney disease
Haemoglobin decreased
Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
Blood potassium increased
Diarrhoea
Fatigue (feeling of tiredness)
Gait disturbance
Hepatic enzyme increased
Malaise (a feeling of general discomfort or uneasiness)

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 36.84%
Carcinoid Syndrome (syndrome includes flushing and diarrhoea, and, less frequently, heart failure and bronchoconstriction): 6 people, 31.58%
High Blood Pressure: 3 people, 15.79%
High Blood Cholesterol: 3 people, 15.79%
Pain: 3 people, 15.79%
Diabetes: 3 people, 15.79%
Gout (uric acid crystals building up in the body): 2 people, 10.53%
Infection: 2 people, 10.53%
Fluid Retention (an abnormal accumulation of fluid in the blood): 2 people, 10.53%
Depression: 2 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take Paricalcitol and Klor-con?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously